Losartan Potassium Tablet, Film Coated
Product Images NDC 68071-4471

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-4471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4471 3

This is a description of pharmaceutical product called Losartan Potassium 50mg manufactured by NuCare Pharmaceuticals, Inc. The product comes in the form of 30 tablets in a bottle with lot number 000000. The NDC numbers are 68071-4471-3 and 31722-701-30, and the expiration date is 00-00. It is the prescription medicine and only used as directed by a physician. The product contains some specific ingredients which can be found in the manufacturer's label. It has a warning message that it should be kept out of reach of children and be stored at a controlled temperature of 68-77°F.*

FDA Label Image

Losartanaddress1 (Losartanaddress1)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

The given text seems to be a statistical analysis result of a study. The study examines the adjusted risk reduction percentage, which amounts to 26% with a p-value of 0.001. The rest of the text seems to be a graphical representation, as it shows months on the X-axis and the percentage of patients with either fatal or non-fatal stroke on the Y-axis. Hence, it is likely a part of a graph or chart accompanying the study.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

FDA Label Image

Losartanfigure4 (Losartanfigure4)

The text is a table representation showing the percentage of patents with events and risk reduction in a particular time period of months. The specific details of the events and risk reduction are not available.*

FDA Label Image

Losartanstructure (Losartanstructure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.